Company Filing History:
1 out of 832,843 Years Active: 2004
Title: Christopher Redman: Innovator in Predictive Medicine
Introduction
Christopher Redman is a notable inventor based in Oxford, GB. He has made significant contributions to the field of predictive medicine, particularly concerning the health of pregnant women. His innovative approach has the potential to improve prenatal care and outcomes for mothers and their babies.
Latest Patents
Christopher Redman holds a patent for a predictive test for pre-eclampsia. This method enables healthcare professionals to predict the risk of a pregnant woman developing pre-eclampsia through an analysis of serum levels of screening markers, specifically Inhibin A and free β-hCG. The apparatus designed for this determination enhances the ability to assess the risk based on serum sample analysis.
Career Highlights
Throughout his career, Christopher Redman has focused on advancing medical technology and improving patient care. His work has been instrumental in developing methods that provide critical information to healthcare providers, allowing for timely interventions.
Collaborations
Christopher has collaborated with Nicholas J Wald, a fellow innovator in the field. Their partnership has contributed to the development of groundbreaking medical technologies that address significant health challenges.
Conclusion
Christopher Redman's contributions to predictive medicine, particularly through his patent on pre-eclampsia risk assessment, highlight his commitment to improving maternal health. His innovative work continues to pave the way for advancements in prenatal care.